One of Italy’s most important scientific awards was recently granted to Peter Friedl, M.D., Ph.D., professor of genitourinary medical oncology at The University of Texas MD Anderson Cancer Center for his remarkable study into cancer growth and imaging, metastasis and therapy response.
Friedl received the 13th annual City of Florence Prize in Molecular Sciences, a prize that is historically granted to important and distinguishable researchers such Robert C. Gallo. M.D.; AIDS research pioneer J. Craig Venter, Ph.D., an expert in human genome sequencing; and the Nobel laureates Robert Hubert and Ada Yonath.
The City of Florence’s science prize, which was founded by the Center for Magnetic Resonance, the Italian Chemical Society, the Sacconi Foundation, and the Ente Cassa di Firenze and Banca CR Firenze, is attributed for progress made in critically important technical advancements that can provide valuable insights into biomedical processes
Ethan Dmitrovsky, M.D., provost and executive vice president at MD Anderson said: “Dr. Friedl’s accomplishments are internationally known and this prestigious award only confirms the significance of his work. To be recognized along with other scientific leaders is truly an honor and one that reflects the high caliber of research that is daily pursued at MD Anderson.”
The University of Florence’s Center for Magnetic Resonance, sponsoring the City of Florence Prize award, said that Friedl was awarded because of “developing innovative technologies for dynamic detection of cell processes … his deep experience in the field of microscopy has allowed him to develop a novel method to obtain 3D images of living tissue, making them fluorescent rays with low energy. This technique is ideal for observing the dynamics of the cells in the deep tissues of the tumor.”